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Summary
Polycomb group (PcG) proteins exert essential functions in the most disparate biological processes.
The contribution of PcG proteins to cell commitment and differentiation relates to their ability to
repress transcription of developmental regulators in embryonic stem (ES) cells and in committed cell
lineages, including skeletal muscle cells (SMC). PcG proteins are preferentially removed from
transcribed regions but the underlying mechanisms remain unclear. Here, PcG proteins are found to
occupy and repress transcription from an intronic region containing the microRNA miR-214 in
undifferentiated SMC. Cell differentiation coincides with PcG disengagement, recruitment of the
developmental regulators MyoD and myogenin, and activation of miR-214 transcription. Once
transcribed, miR-214 negatively feeds back on PcG by targeting the Ezh2 3′UTR, the catalytic subunit
of the PRC2 complex. miR-214-mediated Ezh2 protein reduction accelerates SMC differentiation
and promotes unscheduled transcription of developmental regulators in ES cells. Thus, miR-214 and
Ezh2 establish a regulatory loop controlling PcG-dependent gene expression during cell
differentiation.
Introduction
Histone H3K27 trimethylation (H3K27me3) is mediated by Ezh2, the catalytic subunit of
Polycomb group (PcG) proteins that, with Suz12 and Eed, constitutes the Polycomb Repressive
Complex 2 (PRC2) (Cao et al., 2002). The PRC1 complex includes Bmi1, Ring1A and B and
can function independently of PRC2 (Schoeftner et al., 2006), (Pasini et al., 2007). However,
often H3K27me3 serves as a docking site for PRC1 recruitment, which promotes chromatin
remodeling and condensation to ensure gene silencing (Francis et al., 2001). PcG proteins
regulate developmental gene expression patterns by repressing transcription of key
developmental regulators in ES cells (Bernstein et al., 2006; Boyer et al., 2006; Bracken et al.,
2006; Lee et al., 2006). Indeed, Suz12 and Eed-null ES cells express PcG-target genes that are
normally repressed (Boyer et al., 2006; Chamberlain et al., 2008; Lee et al., 2006; Pasini et al.,
2007). Ezh2-deficient ES cells could not be established (O'Carroll et al., 2001), leading to the
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suggestion that Ezh2 may be crucial for the propagation of the pluripotent state (Erhardt et al.,
2003). However, the role of PcG proteins in the maintenance of ES pluripotency remains
controversial (Silva and Smith, 2008). In addition to ES cells, PcG proteins may regulate
differentiation of a wide range of cell lineages. For instance, decreased H3K27me3 and PcG
binding at certain neuron-specific genes occur during ES cell differentiation into neural
precursor cells (Boyer et al., 2006) and during neuronal differentiation (Bracken et al., 2006),
at glial-specific genes in neural progenitor cells (Mikkelsen et al., 2007), and at epidermal
genes during keratinocyte maturation (Sen et al., 2008). Moreover, conditional Ezh2 ablation
has revealed its critical role in controlling B cell development and immunoglobulin gene
rearrangement (Su et al., 2003), and gene expression in epidermal basal cells (Ezhkova et al.,
2009). Whilst PcG binding and H3K27me3 marks are lost from most transcribed chromatin
regions, the underlying mechanisms remain unclear.
Skeletal myogenesis provides a useful biological context within which to examine PcG
regulation. The locus for the muscle developmental regulator MyoD is occupied by PcG
proteins, bivalently marked by H3K4me3 and H3K27me3, and silent in ES cells (Lee et al.,
2006). In skeletal muscle cells (SMC), PcG proteins and H3K27me3 no longer occupy the
MyoD locus, allowing for its transcriptional activation. Although MyoD is expressed in
undifferentiated SMC, certain MyoD-target genes remain occupied by PcG proteins, marked
by H3K27me3, and not expressed. It is only after additional signals initiate the complete
myogenic program that PcG binding and H3K27me3 are lost at MyoD-target loci, resulting in
appropriate muscle gene expression and SMC differentiation (Caretti et al., 2004). Here, we
describe a mechanism for PcG regulation. A genomic region containing the miR-214
transcriptional unit is occupied and repressed by PcG proteins in undifferentiated SMC. During
differentiation, PcG proteins are disengaged and the developmental regulators MyoD and
myogenin are recruited at the miR-214 region, resulting in its transcriptional activation. Once
transcribed, miR-214 loops back to target the Ezh2 3′UTR, thus reducing Ezh2 protein
accumulation. Indicating the Ezh2 3′UTR is a bona fide target and is accessible to miR-214 in
other cell types, miR-214 expression decreases Ezh2 protein levels also in mouse embryonic
fibroblasts (MEFs) and mouse ES cells. miR-214-induced Ezh2 protein reduction is
accompanied by accelerated differentiation of SMC and derepression of developmental
regulators that are PcG targets in ES cells. Thus, miR-214 can impact transcription controlled
by PcG by regulating Ezh2 protein levels.
Results
The Ezh2 mRNA-But Not Its Corresponding Protein-is Detected in Adult Skeletal Muscle
Ezh2 mRNA expression decreases during skeletal muscle development (Laible et al., 1997)
(Caretti et al., 2004). However, when amplified by RT-PCR, Ezh2 transcripts were detected
in both liver and skeletal muscle of adult mice (Figure 1A). In skeletal muscle, Ezh2 mRNA
was not effectively translated, as surmised by the absence of Ezh2 protein (Figure 1B). This
observation suggested that Ezh2 mRNA might undergo post-transcriptional regulation in
skeletal muscle.
miR-199/214 Are Expressed in Differentiating Skeletal Muscle Cells
Alignment of the Ezh2 3′UTRs of several species revealed a high degree of evolutionary
conservation (Figure S1A), and the presence of putative sites for several miRNAs (Figure 1C),
including those for miR-98, miR-101, miR-199, miR-214, and miR-26. miR-101, a microRNA
that regulates Ezh2 in cancer (Varambally et al., 2008) (Friedman et al., 2009) was barely
detectable and its expression, like that of miR-98, was not developmentally modulated in
C2C12 cells (Figure S1B, C). Thus, we focused on miR-199 and 214. Both miRNAs were
hardly detected in undifferentiated, sub-confluent C2C12 myoblasts (Figure 1D, E, GM,
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growth medium 50%), but clearly expressed when cells reached full confluency (100% GM)
and underwent differentiation (DM, differentiation medium). Genome-wide expression
profiling also indicates that the primary miR-199/214 transcript is up-regulated during C2C12
cell differentiation (Caretti et al., 2006) (GEO, GDS2515 record, Mm.29567,
http://www.ncbi.nlm.nih.gov). Increased miR-199 and 214 accumulation in fully confluent
cells coincided with initial Ezh2 protein reduction (Figure 1F, 100% GM) and cell
differentiation, as indicated by the appearance of myogenin transcripts (Figure 1G, 100% GM).
Similar expression profiles of miR-199 and 214 were observed in mouse primary myoblasts
(Figure 1H-J). In developing mouse embryos (9.5 d.p.c), miR-214 was expressed in several
anatomical structures, including the somites, where muscle precursors are initially specified
and differentiate (Figure S1F). Consistent with its non-muscle-restricted expression in the
embryo, mir-214 was expressed in confluent CH310T1/2 mouse fibroblasts, and coincided
with reduced Ezh2 protein accumulation (Figure S1D). miR-26a may be relevant at later stages
of differentiation, as its expression occurs in terminally differentiated C2C12 cells (Wong and
Tellam, 2008), well after the initial Ezh2 protein decrease.
miR-214 Targets the Ezh2 3′ UTR in Skeletal Muscle Cells
Grafting the Ezh2 3′UTR to a luciferase reporter construct reduced luciferase activity in
differentiating C2C12 cells (Figure 2A, B, p<0.0005, Figure S2A). The luciferase-Ezh2 3′UTR
construct was less active- or more repressed-in differentiating than in proliferating C2C12 cells
(Figure 2B). We tested whether luciferase repression may be ascribed to miR-199, miR-214,
or both by modifying their presumptive sites (Figure 2A). Mutations of these sites were
predicted to reduce pairing with their corresponding miRNAs, as suggested by increased free
energy hybridization values (ΔG) (Figure 2A). Luciferase activity of wild-type (WT) or
miR-199 mutant (199Mut) Ezh2 3′ UTR construct was comparably reduced (Figure S2B).
These data suggest that miR-199 has no significant role in Ezh2 3′UTR regulation. Conversely,
luciferase activity of the single (214Mut) or double mutants (199/214Mut) was similar to that
of control vector (Figure S2A,B, and Figure 2B), indicating that the presumptive miR-214 site
is required to mediate repression. To further assess the relevance of miR-214 to Ezh2 3′UTR
regulation, WT or 214Mut Ezh2 3′UTR reporter construct was introduced in C2C12 cells
expressing either wild-type or mutant miR-214 (Figure S2C). Cells expressing miR-214-wt,
but not miR-214-mut, further suppressed the luciferase activity of WT but not 214Mut construct
(Figure 2C). The repression of WT construct observed in cells expressing miR-214-mut (Figure
2C, right panel) was similar to that in control cells (Figure 2C, left panel), and is likely due to
endogenous miR-214. Next, we depleted endogenous miR-214 in C2C12 cells by transfecting
chemically modified, single-stranded anti-miR-214 oligomers (Figure S2D). MiR-214
depletion relieved the repression exerted by the Ezh2 3′UTR on luciferase activity (Figure 2D).
Overall, these results are consistent with a direct targeting of Ezh2 3′UTR by miR-214.
The putative miR-214 site within the Ezh2 3′UTR is atypical, as it does not conform to the
canonical seed rule (pairing to the 5′ region of the miRNA centered on nucleotides 2-7).
Therefore, we felt it necessary to rigorously probe for miR-214 pairing to Ezh2 mRNA. To
this end, the Argonaute-2 (Ago2) protein –an integral component of the RISC complex- was
immunoprecipitated from extracts of C2C12 cells (Figure 2E, top panel; Figure 2F, top panel)
expressing either exogenous wild-type, mutated miR-214, or control miR-22. The
immunoprecipitated materials –along with control reactions- were processed to detect Ezh2
mRNA. Endogenous Ezh2 mRNA was significantly enriched in Ago2-containing protein
complexes derived from wild-type -but not control, miR-22, or mutated -miR-214- C2C12
expressing cells (Figure 2F, lower panel). We confirmed the presence of miR-214 in the Ago2-
containing complex (Figure S2E). In a second set of experiments, C2C12 cells were transfected
with biotinylated wild-type or mutated miR-214 RNA duplexes, respectively. The transfected
RNA duplexes were captured by incubating C2C12 cell extracts on streptavidin-coated agarose
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beads (Figure 2E, bottom panel), and the purified materials processed for Ezh2 mRNA
detection. Ezh2 mRNA was enriched in extracts from cells transfected with wild-type- but not
mutated-miR-214 (Figure 2G). Target specificity was indicated by lack of amplification of
SIRT1- an mRNA not affected by miR-214 (Figures 2G and S4C). Finally, to address the role
of the predicted, but atypical, miR-214 site within the Ezh2 3′UTR, extracts derived from
C2C12 cells transfected with control, WT or 214Mut Ezh2 3′UTR-luciferase reporter
constructs were immunoprecipitated with Ago2 antibodies or unrelated IgG. The
immunoprecipitated materials were processed to detect the luciferase-Ezh2 3′UTR hybrid
mRNA. A significantly higher mRNA enrichment was observed in Ago2-immunoprecipitated
extracts of cell transfected with the WT Ezh2 3′UTR-luciferase reporter compared to those of
214Mut Ezh2 3′UTR-luciferase reporter-transfected cells (Figure 2H). Overall, the results of
these experiments indicate that a miR-214-programmed RISC complex can specifically target
the Ezh2 3′UTR in C2C12 cells.
Epigenetic and Functional Characterization of the miR-199/214 Genomic Region in
Undifferentiated and Differentiated Skeletal Muscle Cells
miR-199/214 are co-transcribed from a conserved antisense intronic transcript at the dynamin3
(Dnm3) locus (Loebel et al., 2005). Both sense Dnm3 and antisense (Dnm3os) transcripts are
expressed in skeletal muscle (Loebel et al., 2005). Since PcG proteins occupy muscle-specific
genes in undifferentiated C2C12 cells (Caretti et al., 2004) and because of the miR-214
regulated expression during differentiation (Figure 1E), we analyzed the genomic region (∼
10 Kb) surrounding and encompassing the miR-199/214 transcript by chromatin
immunoprecipitation coupled to DNA microarray analysis (ChIP-chip).
In undifferentiated C2C12 myoblasts, when miR-214 is not expressed, the miR-199/214 region
was occupied by Suz12, Eed (PRC2), and Bmi1 (PRC1) proteins (Figure 3A). Consistent with
H3K27me3 being a mark for PRC1 recruitment, the region bound by Bmi1 displayed
enrichment for H3K27me3. The initiating (hypophosphorylated) form of RNA polymerase II
(RNAP2) and H3K4me3 were also detected at the miR-199/214 locus in MB (Figure 3B).
H3K4me3 is restricted to the sites of transcription initiation and has been successfully
employed to identify the location of miRNA promoters (Marson et al., 2008). The data indicate
that this genomic region has the characteristics of a miRNA promoter where transcriptional
pausing may be mediated by PcG proteins (Breiling et al., 2001; Guenther et al., 2007; Saurin
et al., 2001; Sessa et al., 2007; Stock et al., 2007).
In differentiated C2C12 myotubes, Suz12, Eed, and Bmi1were reduced near the putative start
site of miR-199/214 transcription (TSS) (Figure 3C). These modifications were accompanied
by increased RNAP2 occupancy, maintenance of H3K4me3, and recruitment of MyoD and
myogenin (Figure 3D). Sequence analysis of the region surrounding the MyoD/myogenin
peaks revealed the presence of putative E-boxes, the canonical DNA binding sites for MyoD/
myogenin. The sequences of three E-boxes display fairly strong evolutionary conservation,
with one of these three (E3) being the closest to the peak of MyoD/myogenin binding (Figure
S3A). Despite reduced recruitment of both PRC2 and PRC1 proteins near the miR-199/214
TSS, a new peak of H3K27me3 was observed in MT at a region within the putative
miR-199/214 transcript, just upstream of miR-214 domain (Figure 3C). This shifted peak of
H3K27me3 may reflect nucleosome remodeling that accompanies muscle differentiation and
is reminiscent of recent observations in Drosophila where H3K27me3 was found to be enriched
not only at Polycomb Responsive Elements but was broadly distributed in gene flanking
regions (Schwartz et al., 2006). The results of the ChIP-chip experiments were confirmed by
quantitative ChIP (Figure S3D). As control for specificity of the ChIP-chip data at the miR-214
locus, we analyzed H3K27me3 and Suz12 binding at the muscle creatine kinase (Ckm) (Caretti
et al., 2004) and MyoD loci (Lee et al., 2006). In agreement with previous studies, the Ckm
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enhancer was H3K27me3-marked and occupied by Suz12 in undifferentiated C2C12
myoblasts but not differentiated myotubes (Figure S3B, D) (Caretti et al., 2004). Neither
H3K27me3 nor Suz12 enrichment were observed at the MyoD locus in either myoblasts or
myotubes (Figure S3C) (Lee et al., 2006). Suz12 enrichment at the PcG target Pax6 gene (Lee
et al., 2006) in C2C12 myoblasts was comparable to that observed at miR-199/214 region
(Figure S3E).
To test for the regulatory function of PcG proteins at the miR-199/214 region, either Suz12 or
Ezh2 were depleted by siRNA in undifferentiated C2C12 myoblasts. Lowering either protein
(Figure 3E, G) increased miR-214 expression (Figure 3F, H). Consistent with PcG binding to
the myogenin promoter (Bracken et al., 2006) and the regulatory role exerted by miR-214 on
myogenin expression (see below, Figure 4), either Suz12 or Ezh2-knock-down increased also
myogenin expression (Figure 3F, H). These results indicate that PcG proteins occupy and
repress transcription of the miR-199/214 region in undifferentiated C2C12 myoblasts.
Moreover, they reveal that the miR-199/214 region is a direct target of MyoD and myogenin.
miR-214 Expression Reduces Ezh2 Protein, Accelerates Muscle Gene Expression, and
Promotes Muscle Differentiation
We evaluated the functional significance of our findings by analyzing C2C12 cells transduced
with a retrovirus expressing miR-214 (Figure 4A, left panel). These cells had reduced Ezh2
protein (Figure 4A, right panel), but similar Ezh2 mRNA levels (Figure 4B). Mir-214-
transduced cells initiated premature expression of myogenin and myosin heavy chain (MHC)
(Figure 4A). Moreover, miR-214-expressing cells contained a higher percentage of MHC-
positive cells (Figure 4C). Cells transduced with either miR-214 mutant (Figure 4C, D) or
miR-22 (Figure S4A,B) -for which there are no putative sites within the Ezh2 3′UTR- behaved
as control cells.
To further probe the concept that miR-214 affects muscle gene expression by modulating Ezh2,
we reduced Ezh2 in C2C12 cells by siRNA, or in primary myoblasts derived from mice
harboring floxed Ezh2 alleles by adenoviral-mediated expression of the Cre recombinase. In
siRNA Ezh2-depleted C2C12 cells, expression of both myogenin and MHC was prematurely
initiated. Similarly, reducing Ezh2 in mouse primary myoblasts resulted in increased myogenin
expression (Figure 4E).
In addition to Ezh2, miR-214 is likely to affect other targets involved in regulating muscle gene
expression and differentiation. A bioinformatics search identified the 3′ UTR of the
deacetylases SIRT1 and HDAC9 (Figure S4C), both regulators of muscle differentiation (Fulco
et al., 2003) (Haberland et al., 2007), as potential miR-214 targets. However, neither protein
was influenced by miR-214 expression (Figure S4C). To continue testing for the miR-214-
Ezh2 link, we blocked endogenous miR-214 with chemically modified, single-stranded anti-
miR-214 oligomers. C2C12 cells receiving anti-miR-214 oligomers and prompted to
differentiate had increased Ezh2 and reduced myogenin and MHC protein levels (Figure 4F).
Finally, we employed an Ezh2 version - devoid of its 3′UTR region- expected to escape
miR-214-dependent regulation. Indeed, endogenous Ezh2 protein-but not transfected 3′UTR-
less Myc-tagged Ezh2- was reduced in miR-214-expressing C2C12 cells (Figure 4G).
Moreover, anticipated myogenin expression induced by miR-214 was effectively counteracted
by 3′UTR-less Ezh2 (Figure 4G). Overall, the results support the contention that Ezh2 is a
specific and functionally relevant target of miR-214 in skeletal muscle cells.
Next, we wished to evaluate the role of mir-214 on differentiation of mouse primary myoblasts.
Individual myofibers isolated from the soleus muscle of 8-week-old mice were plated (Figure
4H, left panels) and transduced with control or miR-214-expressing lentivirus. Cultures
transduced with miR-214 lentivirus contained a higher percentage of myogenin-positive cells,
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compared to those of control transduced myofibers (∼50% increase of myogenin-positive cells,
p<0.05) (Figure H-K). Effects of comparable magnitude were noted for miR-233 in
hematopoietic progenitor cells (Chen et al., 2004). Thus, miR-214 promotes differentiation not
only of an established skeletal muscle cell line (i.e., C2C12) but also of myofiber-derived
myoblasts. In zebrafish, miR-214 influences formation of slow muscle cell types by targeting
Su(fu), a negative regulator of Hedgehog signaling (Flynt et al., 2007). We aligned zebrafish
with mammalian Su(fu) 3′UTRs and found no conservation of these regions (data not shown).
Accordingly, the levels of mammalian Su(fu) protein were not decreased in miR-214-
expressing C2C12 cells (Figure 4L). Since Ezh2 is transcriptionally down-regulated in
differentiating C2C12 cells (Caretti et al., 2004) (Figure S1E), it could be argued that miR-214
overexpression may indirectly promote muscle cell differentiation without necessarily
targeting Ezh2. To address this issue, we evaluated how miR-214 affects Ezh2 protein in MEFs,
which do not undergo cell lineage commitment and differentiation. MEFs were transduced
with the miR-214 retrovirus and Ezh2 mRNA and protein evaluated. Ezh2 protein was reduced
in miR-214-wt, but not miR-214-mut expressing MEFs (Figure 4M), whereas MEFs
transfected with chemically modified, single-stranded anti-miR-214 oligomers had increased
Ezh2 protein (Figure 4N). miR-214 overexpression did not reduce the Ezh2 mRNA levels
(Figure 4O). Overall, these results suggest that miR-214 directly targets Ezh2's 3′UTR in both
C2C12 cells and MEFs and regulates skeletal muscle differentiation.
miR-214 Targets Ezh2's 3′UTR During Retinoic Acid-Induced Differentiation and Modifies
Transcription of Developmental Regulators in Pluripotent ES Cells
Given the regulatory role exerted by PcG on gene transcription in ES cells, we extended our
studies to these cells. Depending on the culture conditions, ES cells can be differentiated into
various cell types. Retinoic acid (RA) promotes repression of the pluripotent markers Oct-4,
Sox2, and Nanog (Chambers and Smith, 2004), and activation of the Hox genes (Langston et
al., 1997), Sox1(Zhao et al., 2004), the Wnt antagonist Dkk1 (Verani et al., 2007), and of the
neuronal marker nestin (Okabe et al., 1996). Pluripotent ES cells formed rounded, tightly
packed colonies with well-defined margins and expressed Oct-4 and Sox2 (Figure S5A,B).
Once exposed to RA, ES cells changed their morphology to assume a flattened neuronal-like
phenotype (Figure S5A), down-regulated expression of Oct-4 and Sox2, initiated expression
of Sox1, Hoxa1, Hoxb1, and nestin (Figure S5B,C).
RA-induced ES differentiation was accompanied by increased expression of both primary and
mature miR-214 and reduced Ezh2 protein levels (Figure 5A,B). To causally link miR-214 to
RA-mediated Ezh2 down-regulation, ES cells were transfected with either the WT Ezh2-3′
UTR or 214Mut reporter construct. ES cells exposed to RA suppressed luciferase activity of
WT but not 214Mut construct, indicating that, as observed in SMC, miR-214 targets the Ezh2
3′UTR also in ES cells (Figure 5C). To further study the role of miR-214, ES cells were
transduced with control, miR-214-wt or miR-214-mut-expressing lentivirus, respectively
(Figure 5D). MiR-214-wt, but not miR-214-mut, reduced the Ezh2 protein without affecting
the mRNA levels (Figure 5D, middle and right panels). ES cells transduced with miR-214-wt
and exposed to RA displayed increased Dkk1 and nestin expression, when compared to RA-
treated control cells (Fig.5E). Of interest, Dkk1 is occupied by PcG and upregulated in Suz12-
null ES cells (Boyer et al., 2006).
MiR-214 expression in ES cells kept in their pluripotent state repressed expression of the
pluripotent marker Oct-4 (Figure 5D, middle panel) and was sufficient to de-repress
transcription of the developmental regulators Gata-4, Sox17, and Pax7 (Figure 5F), three PcG
targets whose expression is increased in Suz12- and Eed-null ES cells (Boyer et al., 2006)
(Lee et al., 2006). Since Oct-4 expression is not reduced in Ezh2-/- ES cells (Shen et al.,
2008), miR-214 may have additional, Ezh2-independent, targets. Alternatively, it is possible
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that a subpopulation of cultured Ezh2-/- ES had reduced levels of Oct-4, and, as a consequence,
may have lost cell identity, pluripotency, and self-renewal potential (Niwa et al., 2000). MyoD
transcription was not activated by miR-214 (Fig.5F, right panel) (see Discussion). MiR-214-
expressing ES cells assumed a flattened phenotype and displayed reduced staining for alkaline
phosphatase, a marker of pluripotency (Figure 5G). Overall, these results indicate that miR-214
can reduce Ezh2 and derepress transcription of developmental regulators in ES cells.
Discussion
During cell lineage commitment and differentiation, H3K27me3 is reduced at many genes,
including those encoding for developmental regulators. This phenomenon often coincides with
transcriptional activation. The important role played by PcG proteins in ES cell biology has
been reinforced by the discovery that H3K27me3 marks are reestablished at genes for
developmental regulators during reprogramming of differentiated cells into induced
pluripotent cells (iPS) (Maherali et al., 2007) (Mikkelsen et al., 2008; Wernig et al., 2007).
Because of the important functions exerted, decreased H3K27me3 at selected genes during
cell commitment and differentiation may be robustly regulated by independent and coherent
mechanisms. Reduced deposition and active removal of the H3K27me3 mark may account for
it. Indeed, PcG expression is developmentally regulated (Caretti et al., 2004) (de la Cruz et al.,
2007) (Silva et al., 2003) and H3K27me3 can be erased by the UTX/JMJD3 demethylase
complex (Cloos et al., 2008).
Our findings provide evidence that miR-214 introduces an additional level of PcG regulation
in different cell types via a posttranscriptional mechanism. miRNAs have emerged as central
regulators of biological processes. The repressive effect of a given miRNA on individual
proteins is relatively small (Selbach et al., 2008), rarely exceeding 1.5-2 fold (Baek et al.,
2008). Perhaps because of their limited impact on protein accumulation, miRNAs often act in
concert with other regulatory processes, such as reduced transcription (Figure S1E). For
instance, an upstream event may oppositely regulate transcription of the miRNAs and their
targets mRNAs (Alon, 2007b; Tsang et al., 2007). With the additive nature of these two
regulatory mechanisms, the repressive effect of miRNAs on target expression can be modest
yet functionally meaningful. The results of the experiments reported here indicate that
miR-214-dependent regulation of Ezh2 protein is relevant not only for cell lineage-specific
differentiation (i.e., SMC) but also influence ES cell commitment. Pluripotent ES cells, which
express very low levels of miR-214 (Marson et al., 2008), readily activate miR-214
transcription when induced to differentiate, a process that is accompanied by reduction of the
Ezh2 protein levels. Moreover, miR-214 expression in pluripotent ES cells is sufficient to
derepress transcription of the developmental regulators Gata-4, Sox17, and Pax7. These
regulators are PcG-targets whose expression is also up regulated in both Suz12-null (Pasini et
al., 2007) (Lee et al., 2006) and Eed-null ES cells (Boyer et al., 2006). In addition, Pax7 plays
a central role in muscle development (Seale et al., 2000) and, following transcriptional
activation, its locus shows reduced levels of Suz12 occupancy in muscle cells relative to ES
cells (Lee et al., 2006). MyoD's locus is occupied by PcG proteins and H3K27me3 in ES cells
(Lee et al., 2006). Nonetheless, in contrast to other PcG targets, MyoD expression is not
activated in either Suz12-null (Lee et al., 2006) or Eed-null ES cells (Boyer et al., 2006), nor
was it induced by miR-214 in ES cells (Figure 5F), indicating that different PcG-targets
undergo distinct regulation in ES cells. For some of them, such as MyoD, simple transcriptional
derepression may be insufficient to activate transcription in the absence of positive regulators.
The miR-214 site within the Ezh2 3′UTR does not obey the canonical seed rule (Bartel,
2009). In this respect, it is of interest to note that a recent study found that ∼ 30% of Ago-
mRNA clusters have no predicted seed matches among the top 20 Ago-miRNA families (Chi
et al., 2009). These findings indicate that miRNA pairing may, under circumstances yet to be
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defined, tolerate single mismatch, wobble or bulge nucleotides (Vella et al., 2004) (Didiano
and Hobert, 2006) (Tay et al., 2008).
Mice with experimental ablation of the miR-199/214 locus display developmental defects,
including skeletal muscle hypoplasia, suggesting a relevant role of these microRNAs in skeletal
myogenesis (Watanabe et al., 2008). Several miRNAs influence myogenesis (Williams et al.,
2009). In particular, miR-26a regulates Ezh2 in SMC and promote their differentiation (Wong
and Tellam, 2008). It is likely that miR-214 and miR-26a affect Ezh2 at distinct developmental
steps. Indeed, miR-214 accumulation is evident at the very initial stages of cells differentiation
–coinciding with the initial and most evident Ezh2 protein reduction (Figure 1E,F)- whereas
miR-26a could not be detected until SMC had completed their terminal differentiation (Wong
and Tellam, 2008).
The link between mir-214 and PcG proteins in muscle cells may be rationalized in a working
model where Ezh2 transcriptional down-regulation occurring at the initial phases of muscle
differentiation (Caretti et al., 2004) (Figure 6A) would promote, along with MyoD and/or
myogenin recruitment, expression of miR-214, which in turn would negatively feedback on
Ezh2 by inhibiting translation of its mRNA. This relation is best described as a two-node
bistable feedback loop (Alon, 2007a) (Figure 6B), a network motif that, by providing a lock-
on-mechanism, is conducive to epigenetic inheritance and, as such, often recurs in
developmental transcription networks. This network may have been selected to increase
robustness of the system to effectively and rapidly reduce Ezh2 availability at critical stages,
such as those regulating SMC differentiation.
Experimental Procedures
Cells, Retroviral, Adenoviral, and Lentiviral Constructs, Viral Transduction and Transient
Transfection
A detailed description of the reagents and methods is reported in Supplemental Experimental
Procedures.
Myofiber Isolation, Culture, and Lentiviral Infection
Mouse soleus muscles from 8 weeks-old C57BL mice were isolated and incubated in DMEM
with 0.2% (w/v) collagenase I. Individual myofibers were serially diluted and subsequently
manually isolated in GM. For infection, myofibers were cultured for 36 hrs post-isolation prior
to infection. Isolated myofibers were incubated with viral supernatants diluted 1:1 in GM,
supplemented with polybrene (4μg/ml). Infected cells were incubated for an additional 72 hrs,
and then analyzed by immunofluorescence microscopy and quantitative PCR.
Reporter Constructs, Mutagenesis, and Luciferase Reporter Assay
A detailed description of the reagents and methods is reported in Supplemental Experimental
Procedures.
Ribonuclease Protection Assay (RPA) and Northern Blot Hybridization
Total RNA was isolated from C2C12 cells using Trizol Reagent (Invitrogen). The expression
of miR-199a-5p, miR-214, and miR-101b was determined by RPA using mirVana miRNA
Detection Kit according to the manufacturer's instruction (Ambion). A detailed description of
the reagents and methods is reported in Supplemental Experimental Procedures.
Sequence Alignments and microRNA Target Prediction
The methods are reported in Supplemental Experimental Procedures.
Juan et al. Page 8
Mol Cell. Author manuscript; available in PMC 2010 October 9.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Whole Mount In Situ Hybridizations
Reagents and methods are reported in Supplemental Experimental Procedures.
Tiling of microRNA regions on DNA arrays, ChIP, and promoter-specific PCR
Sequences upstream of the miR-199-a2/214, Ckm, and MyoD loci were analyzed and probes
were designed for the ∼10kb upstream by the methods described in (Boyer et al., 2005). Probes
were spaced approximately ∼250 bp apart. Chromatin immunoprecipitation (ChIP) was
performed as described in. Briefly, chromatin fragments were immunoprecipitated overnight
at 4°C. After reversal of crosslinks, enriched fragments were amplified using a two-step
ligation-mediated PCR (LM-PCR) protocol and fluorescently labeled with Cy5 dUTP
(Amersham). Labeled fragments were hybridized to DNA arrays in Agilent hybridization
chambers at 40° C for ∼40 hrs against a Cy3 dUTP labeled unenriched reference sample
(H3K27me3 immunoprecipitations were hybridized against core H3 immunoprecipitations to
normalize for total histone H3 density). Arrays were washed and scanned using an Agilent
DNA microarray scanner. Unprocessed enrichment ratios from the DNA arrays were examined
to look for evidence of binding.
RNA interference and anti-miR oligonucleotides transfections
Description of the oligonucleotides is provided in Supplemental Experimental Procedures.
Immunofluorescence and immunoblot
The methods and the antibodies employed are described in Supplemental Experimental
Procedures.
Immnuoprecipitation and miRNA pull-down
The methods and the reagents are reported in Supplemental Experimental Procedures.
RT-PCR, Real-Time PCR, and microRNA TaqMan Real-Time PCR
Material and methods are provided in Supplemental Experimental Procedures.
Real-Time PCR Validation of ChIP-chip Data
Description of the material and methods is provided in Supplemental Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ezh2 mRNA and Protein Levels in Mouse Adult Liver and Skeletal Muscle and
microRNAs Expression in SMC
(A) Ezh2 and GAPDH mRNA in the skeletal muscles and livers from three (lanes 1-3) adult
mice. N, negative control without cDNA template. (B) Ezh2 and GAPDH proteins in the same
tissue samples isolated in (A). (C) The putative targeting sites of miRNAs within the Ezh2 3′
UTR are shown in the upper panel. The alignment of each Ezh2 3′UTR/miRNA hybrid is shown
in the lower panel. (D) Expression of miR-199a-5p by Ribonuclease Protection Assay (RPA)
in subconfluent (50% GM, growth medium), confluent (100% GM), or 1, 3, or 5 days
differentiated C2C12 cells (DM, differentiation medium). 5s rRNA was used as a loading
control. (E) Expression of miR-214 and 5s rRNA by RPA in C2C12 cells cultured as described
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in (D). (F) Immunoblot of Ezh2 and GAPDH, and (G) Myogenin mRNA expression. (H) Light
microscopic images of mouse primary myoblasts cultured in growth medium (GM, 50% and
100% confluency) or in differentiation medium for 2 days. (I) miR-199a-5p and (J) miR-214
expression determined by real-time PCR in mouse primary myoblasts cultured as described in
(H). Error bars represent standard deviations (n=3).
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Figure 2. miR-214 Down-Regulates Ezh2 by Direct Targeting Its 3′UTR
(A) Schematic representation of luciferase reporter constructs. The predicted structure of each
base-paired Ezh2 3′ UTR/wild-type or mutated miRNA hybrid is diagrammed, and the
calculated free energy (ΔG) in kilocalories per mole of the 5′ seed region of each hybrid is
shown on the right. The top strand in each diagram represents 5′ to 3′ Ezh2 3′ UTR WT and
mutants (nucleotides in color), and the bottom strand represents the microRNAs. (B) Luciferase
reporters shown in (A) were transfected into C2C12 myoblasts (50%, 100% confluent, or
differentiated in DM for 24 hrs) and luciferase activity was determined 48 hrs after transfection.
The ratio of reporter (Firefly Luciferase, FL) to control plasmid (Renilla Luciferase, RL) in
relative luminescence units was normalized for each reporter to the buffer control and plotted
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as fold increase or decrease of the control value. Error bars represent standard deviations from
3 independent experiments done in triplicate (*** p<0.0005; ** p<0.005). (C) Control
luciferase reporter (pGL3), pGL3 with wild-type Ezh2 3′UTR (WT), or with Ezh2 3′ UTR
mutated miR-214 site (Mut) were transfected into C2C12 cells overexpressing empty vector
(left panel), wild-type miR-214 (miR-214wt, middle panel), or mutated miR-214 (miR-214-
mut, right panel). The sequences of miR-214-wt and the mutations introduced into miR-214-
mut are indicated on the bottom. Luciferase activity was determined as described in (B). ***
p<0.0005; ** p<0.005. (D) C2C12 cells were co-transfected with either control or anti-
miR-214 oligomers, pGL3 (control vector), pGL3-Ezh2 3′ UTR (WT), or pGL3-Ezh2 3′ UTR
mutated miR-214 site (Mut) reporter constructs. Luciferase activity was determined as
described in (B). **** p<10-6. (E) Schematic representation of RNA-immnuoprecipitation
(upper panel) and miRNA pull-down experiments (lower panel). (F) Cell extracts were
prepared from 24 hours differentiated C2C12 cells overexpressing empty vector, wild-type
miR-214, mutated miR-214 or miR-22 and immnuoprecipitated with either Ago2 antibody or
IgG and blotted with Ago2 antibody (top panel). Asterisk indicates 55 kDa IgG heavy chains.
The precipitated RNA was converted to cDNA and amplified by real-time PCR using Ezh2
primers (lower panel). Error bars represent standard deviations (n=3), * p< 0.05, ** p< 0.005.
(G) C2C12 cell extracts were prepared from cells transfected with biotinylated double-strand
RNA miR-214 or miR-214 mutant and subjected to either immunoblot (left panel) or pull-
down assay with streptavidin beads. The pulled-down RNA was converted to cDNA and
amplified by real-time PCR using Ezh2 or SIRT1 primers. Error bars represent standard
deviations from 3 independent experiments. * p < 0.05, ** p< 0.005. (H) Cell extracts from
C2C12 cells transfected with control (pGL3), WT Ezh2 3′UTR (WT), or 214Mut Ezh2 3′ UTR
(Mut) luciferase constructs were immunoprecipitated with either Ago2 antibody or unrelated
IgG. The precipitated RNA was converted to cDNA and amplified by real-time PCR using
primers spanning the luciferase and Ezh2 3′UTR junction. The values were corrected for the
amount of total luciferase –Ezh2 3′ UTR RNAs (either WT or Mut), measured by real-time
PCR. Error bars represent standard deviations from 3 independent experiments, * p< 0.05.
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Figure 3. Epigenetic Characterization of the miR199a/214 Locus in Myoblasts and Myotubes
ChIP-chip analyses of binding of the PRC2 subunits Suz12 and Eed, the PRC1 subunit Bmi1,
and the H3K27 trimethyl mark (A) and the hypophosphorylated form of RNAP2 and the H3K4
trimethyl marker of transcriptional initiation (B) at the miR199a-2/214 locus in proliferating
myoblasts; and the same factors in differentiated myotubes (C) along with analyses of the
myogenic factors MyoD and Myog (D). (E) Real-time PCR analysis of Suz12 and Ezh2 mRNA
(left panel) and immunoblot of Suz12 and tubulin (right panel) in C2C12 myoblasts transfected
with siRNA against Suz12 (si-Suz12). (F) miR-214 and myogenin expression by real-time
PCR in C2C12 cells transfected with si-Suz12. (G) Real-time PCR analysis of Suz12 and Ezh2
mRNA (left panel) and immunoblot of Ezh2 and tubulin (right panel) in C2C12 myoblasts
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transfected with siRNA against Ezh2 (si-Ezh2). (H) miR-214 and myogenin expression by
real-time PCR in C2C12 myoblasts transfected with si-Ezh2. Error bars represent the standard
deviations for n = 3 in (E, F, G, H), * p<0.05; ** p<0.005.
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Figure 4. miR-214 Reduces Ezh2 Protein and Accelerates Muscle Cell Differentiation
(A) miR-214 transcripts (left panel) and time course of protein expression of Ezh2, MHC,
myogenin and tubulin (right panel) in empty vector or miR214-wt retrovirally-transduced
C2C12 cells. Quantification of the band corresponding to Ezh2 protein was performed with
the ImageJ software program. (B) Ezh2 mRNA in empty vector or miR-214-wt C2C12 cells.
(C) MHC immunostaining of C2C12 cells transduced with empty vector, miR-214-wt, or
mir-214-mut and differentiated for 24 hrs. The nuclei were visualized with DAPI. The fusion
index was determined by counting of the number of nuclei present in MHC+ cells per number
of total nuclei and expressed as percentage. Error bars represent the standard deviations. (D)
Immunoblot of Ezh2, myogenin, and tubulin in C2C12 cells transduced with empty vector,
miR-214-wt, or mir-214-mut and differentiated for 12 hrs. (E) Immunoblot of Ezh2, MHC,
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myogenin and tubulin in C2C12 cells transfected with Ezh2 siRNAs (left panel) and
immunoblot of Ezh2, GAPDH, and myogenin mRNA in Ezh2 flox/flox primary myoblasts
infected with adenoviruses expressing Cre recombinase (right panel). (F) Immunoblot of Ezh2,
MHC, myogenin and tubulin in C2C12 myoblasts transfected without (-), or with scrambled
or anti-miR-214 oligomers. Bands corresponding to Ezh2 protein were quantified using the
NIH Image J software. (G) Immunoblot of Ezh2, Myc, myogenin and tubulin of extracts
derived from C2C12-expressing wt or mutated miR-214 cells transfected with pCDNA3
(empty vector) or pCDNA3-Myc-tagged-Ezh2 vector, and differentiated for 12 hrs. The signal
corresponding to the endogenous Ezh2 protein in C2C12 cells expressing exogenous Ezh2-
myc and miR-214 WT was reduced by ∼ 40% when compared to control. The miR-214 mutant
had no effect on endogenous Ezh2. Quantification was performed with NIH ImageJ software.
(H) Light microscopic images of myofibers (left panels) and immunofluorescence staining of
myogenin (red) and counterstained with DAPI (blue) in myofiber-derived MSCs (right panel)
infected with either empty vector (upper panel) or miR-214 (lower panel) expressing lentivirus.
(I) Myofiber-derived MSCs were assayed for myogenin expression and expressed as a
percentage of total myofiber- derived MSCs analyzed (empty vector, blue bar, n=5, 1712 total
cells; miR-214, red bar, n=3, 2318 total cells, * p<0.05). (J) Real-time PCR analysis of
myogenin expression in myofiber-derived MSCs transduced with empty vector or miR-214.
Data represents pooled total RNA from three independent infections and is presented as
averaged replicates (**p<0.001). (K) Real time PCR analysis of miR-214 expression in
myofiber-derived MSCs transduced with empty vector or miR-214. (L) Immunoblot of Ezh2,
Su(fu), and tubulin in empty vector or miR-214-wt retroviral transduced C2C12 cells. (M)
Immunoblot of Ezh2 and tubulin in MEFs transduced with empty vector, miR-214-wt, or
mir-214-mut. 214-1 and 214-2 represent two different experiments conducted with miR-214-
wt constructs. (N) Immunoblot of Ezh2 and tubulin in MEFs non-transfected, transfected with
scrambled or anti-miR-214 oligomers. Bands corresponding to Ezh2 protein were quantified
using the NIH Image J software. (O) Ezh2 mRNA expression in empty vector or miR-214-wt
retrovirally-transduced MEFs.
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Figure 5. miR-214 Modulates Gene Expression in ES Cells by Regulating Ezh2 Protein Levels
(A) Real-time PCR of primary (left panel) and mature (right panel) miR-214 in ES cells kept
in medium containing LIF or induced to differentiate by removing LIF and adding RA for 3
d. (B) Immnuoblot of Ezh2 and GAPDH in ES cells cultured in conditions described in (A).
(C) Control luciferase reporter (pGL3), pGL3- Ezh2 3′UTR (WT), or Ezh2 3′ UTR mutated
miR-214 site (Mut) were transfected into ES cells and the luciferase activity was determined
after 3 d treatment with (right panel) or without (left panel) RA. Error bars represent standard
deviations from 2 independent experiments done in triplicate (* p<0.05). (D) Real-time PCR
of primary miR-214 transcripts (left panel), protein expression of Ezh2, Oct-4, and GAPDH
(middle panel), and Ezh2 mRNA expression in empty vector, miR-214-wt or miR-214-mut
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lentiviral-transduced ES cells (right panel). (E) Nestin and Dkk1 mRNA expression in 3 day
RA-induced lentiviral transduced ES cells with empty vector, miR-214-wt or miR-214-mut.
(F) Gata-4, Sox17, and Pax7 mRNA expression in ES cells transduced with empty vector,
miR-214-wt, or miR-214-mut lentivirus. MyoD mRNA expression was evaluated by Taqman
real-time PCR. (G) Alkaline phosphatase assay in empty vector, miR-214-wt or miR-214-mut
lentiviral-transduced ES cells. Differentiated percentage was determined by counting of
colonies with reduced AP staining per number of total colonies. Error bars represent standard
deviations from values of colonies counted in 2 independent experiments (** p<0.005, *
p<0.05).
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Figure 6. PcG-miR-214 feedback loop model
(A) Ezh2 is highly expressed in undifferentiated myoblasts (left part of the model). The initial
phase of cell differentiation (middle part) is characterized by reduced Ezh2 expression and
consequent de-repression of the miR-214 locus. miR-214 feeds back on Ezh2, reducing its
mRNA translation. MyoD/myogenin binding (right part) actively promotes miR-214
transcription, further inhibiting Ezh2 mRNA translation. (B) Double negative feedback loop.
MyoD/myogenin acts to switch the steady state. In undifferentiated myoblasts, Ezh2 is high
and represses miR-214 (left part of the panel). Upon differentiation, MyoD/myogenin
expression is activated, miR-214 is produced and Ezh2 is repressed (right part of the panel).
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